This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Georg Martiny-Baron: Innovator in Melanoma Treatment
Introduction
Georg Martiny-Baron is a notable inventor based in Herbolzheim, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of melanoma. His innovative work has led to the development of a unique compound that targets specific diseases.
Latest Patents
Martiny-Baron holds a patent for a compound known as 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide. This invention relates to the use of pyrimidylaminobenzamide compounds for the preparation of a drug aimed at treating diseases that respond to modulation of Ephrin receptor kinase, particularly EphB4 activity. The patent emphasizes the curative and prophylactic treatment of proliferative diseases and outlines a method for treating such diseases.
Career Highlights
Throughout his career, Martiny-Baron has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Martiny-Baron has collaborated with notable professionals in his field, including Paul William Manley and Juergen Mestan. These collaborations have further enhanced his research and development efforts.
Conclusion
Georg Martiny-Baron is a distinguished inventor whose work in melanoma treatment showcases his innovative spirit and dedication to advancing medical science. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
